Wells Fargo & Company Stoke Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,387 shares of STOK stock, worth $149,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,387

Previous 9,852 15.58%

Holding current value

$149,169

Previous $133,000 15.04%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $16,931 - $26,893	1,535 Added 15.58%	11,387 $153,000
Q1 2024 May 10, 2024	BUY	$4.12 - $14.17 $5,570 - $19,157	1,352 Added 15.91%	9,852 $133,000
Q4 2023 Feb 09, 2024	BUY	$3.37 - $5.4 $5,668 - $9,082	1,682 Added 24.67%	8,500 $44,000
Q3 2023 Nov 13, 2023	SELL	$3.78 - $11.99 $13,944 - $44,231	-3,689 Reduced 35.11%	6,818 $26,000
Q2 2023 Aug 15, 2023	BUY	$7.93 - $13.82 $51,671 - $90,051	6,516 Added 163.27%	10,507 $111,000
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $29,766 - $40,388	3,891 Added 3891.0%	3,991 $33,000
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $1,725 - $3,828	-244 Reduced 70.93%	100 $0
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $2,901 - $5,204	-231 Reduced 40.17%	344 $5,000
Q2 2022 Aug 12, 2022	SELL	$10.36 - $23.93 $10,152 - $23,451	-980 Reduced 63.02%	575 $8,000
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $111,494 - $169,284	-6,486 Reduced 80.66%	1,555 $33,000
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $54,945 - $93,204	-3,034 Reduced 27.4%	8,041 $193,000
Q3 2021 Nov 15, 2021	BUY	$23.65 - $34.44 $142,987 - $208,224	6,046 Added 120.22%	11,075 $282,000
Q2 2021 Aug 16, 2021	SELL	$30.53 - $41.09 $194,995 - $262,441	-6,387 Reduced 55.95%	5,029 $169,000
Q1 2021 May 13, 2021	BUY	$36.08 - $69.81 $122,166 - $236,376	3,386 Added 42.17%	11,416 $444,000
Q4 2020 Feb 09, 2021	BUY	$33.62 - $61.93 $78,334 - $144,296	2,330 Added 40.88%	8,030 $497,000
Q3 2020 Nov 05, 2020	SELL	$22.23 - $37.48 $101,613 - $171,321	-4,571 Reduced 44.5%	5,700 $191,000
Q2 2020 Aug 13, 2020	SELL	$20.26 - $29.73 $221,624 - $325,216	-10,939 Reduced 51.57%	10,271 $245,000
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $356,328 - $724,321	21,210 New	21,210 $486,000

Others Institutions Holding STOK

# of Institutions

121

Shares Held

53.5M

Call Options Held

14K

Put Options Held

8.8K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $516M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Stoke Therapeutics, Inc. Transaction History